Aug 01, 2010
  • Events
  • Articles
  • Images
  • Links
European Society of Cardiology
August 28th - September 1st, 2010
Stockholmsmässan
Stockholm, Sweden

http://www.escardio.org/congresses/esc-2010/Pages/welcome.aspx

Neurowoche
September 21st - September 25th, 2010
Congress Center Rosengarten
Mannheim, Germany

Neurowoche

Transcatheter Cardiovascular Therapeutics (TCT)
September 21st - September 25th, 2010
Washington Convention Center
Washington, DC

http://www.tctconference.com/

Device Alternative to long term warfarin therapy could be an option for patients with non-valvular atrial fibrillation at risk of stroke

The Lancet David R. Holmes, MD, FACC August 15, 2009    READ ARTICLE

Does left atrial appendage occlusion eliminate the need for warfarin

Circulation David R. Holmes, MD, November 10, 2009    READ ARTICLE

Preliminary data suggest LAA occlusion with the WATCHMAN® to be safe and feasible

Journal of the American College of Cardiology, Peter B. Sick, MD April 3, 2007    READ ARTICLE

American Heart Association

American Stroke Association

Anticoagulation Europe

Arrhythmia Alliance UK

Atrial Fibrillation: Resources for Patients

Heart Rhythm Society

HjerneSagen

Mayo Clinic

National Institute for Health and Clinical Excellence

view clinical dataview lancit article
Where's the Watchman being implanted?
 

Events - Upcoming

European Society of Cardiology
Neurowoche
Transcatheter Cardiovascular Therapeutics (TCT)
4th Belgian Heart Rhythm Meeting Arrhythmias for every Cardiologist
American Heart Association (AHA) Scientific Sessions
LAA 2010: How to Close the Left Atrial Appendage

Scientific Literature

Related Materials and Abstracts

Holmes D R et al, Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial, Lancet 2009;374:534-42.
 READ ARTICLE 

Sick P B et al, Initial Worldwide Experience with the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation. J Am Col Cardiol 2007;49:1490-5.
 READ ARTICLE 

Holmes DR, Schwartz R S, Left Atrial Appendage Occlusion Eliminates the Need for Warfarin. Circulation 2009;120:1919-1926.
 READ ARTICLE

See the full list of published articles.
 

Links

American Heart Association

American Stroke Association

Anticoagulation Europe

Arrhythmia Alliance UK

Atrial Fibrillation: Resources for Patients

Heart Rhythm Society

HjerneSagen

Mayo Clinic

National Institute for Health and Clinical Excellence
 

Your are currently browsing this site with Internet Explorer 6 (IE6).

Your current web browser must be updated to version 7 of Internet Explorer (IE7) to take advantage of all of template's capabilities.

Why should I upgrade to Internet Explorer 7? Microsoft has redesigned Internet Explorer from the ground up, with better security, new capabilities, and a whole new interface. Many changes resulted from the feedback of millions of users who tested prerelease versions of the new browser. The most compelling reason to upgrade is the improved security. The Internet of today is not the Internet of five years ago. There are dangers that simply didn't exist back in 2001, when Internet Explorer 6 was released to the world. Internet Explorer 7 makes surfing the web fundamentally safer by offering greater protection against viruses, spyware, and other online risks.

Get free downloads for Internet Explorer 7, including recommended updates as they become available. To download Internet Explorer 7 in the language of your choice, please visit the Internet Explorer 7 worldwide page.